id: alcohol_abstinence_to_ald_progression_mitigation
name: Abstinence from Alcohol Use â†’ Mitigation of Alcoholic Liver Disease Progression
from_node:
  node_id: alcohol_abstinence
  node_name: Abstinence from Alcohol Use
to_node:
  node_id: ald_progression_mitigation
  node_name: Mitigation of Alcoholic Liver Disease Progression
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Abstinence from alcohol eliminates continued hepatotoxic exposure that
  drives liver inflammation and fibrosis'
- 'Step 2: Cessation of alcohol allows hepatocyte regeneration and reduction in inflammatory
  cytokines'
- 'Step 3: Liver fibrosis progression halts and may partially reverse with sustained
  abstinence'
- 'Step 4: Prevention of progression to decompensated cirrhosis and liver failure
  reduces mortality and morbidity'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'O A Abiola et al. 2024. "Cost-Effectiveness Analysis of Deep
    Brain Stimulation for the Treatment of Alcohol Use Disorder and Alcoholic Liver
    Disease.." *medRxiv : the preprint server for health sciences*. https://doi.org/10.1101/2024.08.22.24312455'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.399641'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: fibrosis_stage
  direction: strengthens
  strength: strong
  description: The benefit of abstinence is particularly pronounced at advanced fibrosis
    stages (stage 3 or beyond), where intervention has greatest impact on preventing
    progression to end-stage liver disease
- name: duration_of_abstinence
  direction: strengthens
  strength: moderate
  description: Sustained abstinence over time periods (1-2 years analyzed) is necessary
    for biological benefits to liver tissue
